E-LIB Suche - Ergebnisse für: Bruckert, E

1

Transcriptomic profile helps to identify high-risk heterozy..:

Pirbay, T. ; Carreau, V. ; Guérin, M....
Archives of Cardiovascular Diseases. 117 (2024) 1 - p. S107-S108 , 2024

Link: https://doi.org/10.1016/..

2

Treatment of pediatric heterozygous familial hypercholester..:

Peretti, N. ; Vimont, A. ; Mas, E....
Clinical Nutrition ESPEN. 58 (2023) - p. 568 , 2023

Link: https://doi.org/10.1016/..

3

Towards a readjustment of diagnostic criteria for familial ..:

Bluteau, O. ; Lapidus, N. ; Giral, P....
Archives of Cardiovascular Diseases Supplements. 15 (2023) 1 - p. 108-109 , 2023

Link: https://doi.org/10.1016/..

4

L'adiponectine : marqueur d'athérosclérose infraclinique ? ..:

Vieira Pinto, O. ; Mondelli, A. ; Charpentier, E....
Nutrition Clinique et Métabolisme. 37 (2023) 2 - p. e58 , 2023

Link: https://doi.org/10.1016/..

5

Enrichment of high-density lipoproteins with phosphatidylet..:

Taradeh, M. ; Dahik, V. ; Lhomme, M....
Atherosclerosis. 355 (2022) - p. 72 , 2022

Link: https://doi.org/10.1016/..

6

Predictive factors of statin initiation during childhood in..:

Peretti, N. ; Vimont, A. ; Mas, E....
Atherosclerosis. 355 (2022) - p. 11 , 2022

Link: https://doi.org/10.1016/..

7

Non-calcific atherosclerotic burden in HeFH: The FH-CALC st..:

Gallo, A. ; Carreau, V. ; Mondelli, A....
Atherosclerosis. 355 (2022) - p. 30 , 2022

Link: https://doi.org/10.1016/..

8

Effects of patient characteristics on volanesorsen efficacy..:

Witztum, J.L. ; Gaudet, D. ; Freedman, S....
Atherosclerosis. 355 (2022) - p. 215 , 2022

Link: https://doi.org/10.1016/..

9

Extreme lipoprotein(a) levels and sub-clinical atherosclero..:

Perregaux, J.-F. ; Bruckert, E. ; Gallo, A.
Atherosclerosis. 355 (2022) - p. 60-61 , 2022

Link: https://doi.org/10.1016/..

10

EPH37 High Cardiovascular Disease Risk and Low Lipid-Loweri..:

Ferrières, J ; Farnier, M ; Bruckert, E..
Value in Health. 25 (2022) 12 - p. S198 , 2022

Link: https://doi.org/10.1016/..

11

Final results from the pan-European observational heymans s..:

Ray, K.K. ; Bruckert, E. ; Perrone-Filardi, P....
Atherosclerosis. 355 (2022) - p. 14 , 2022

Link: https://doi.org/10.1016/..

12

Rationale and design of two trials assessing efficacy, safe..:

Reijman, M.D. ; Schweizer, A. ; Peterson, A.L.H....
Atherosclerosis. 355 (2022) - p. 150 , 2022

Link: https://doi.org/10.1016/..

13

Hypercholestérolémie, du dépistage au traitement : quelle p..:

Yelnik, C.M. ; Bruckert, É.
La Revue de Médecine Interne. 42 (2021) 10 - p. 707-713 , 2021

Link: https://doi.org/10.1016/..

14

High TG to HDL ratio plays a significant role on atheroscle..:

Scicali ; D'Erasmo, L. ; Cluzel, P....
Atherosclerosis. 331 (2021) - p. e237 , 2021

Link: https://doi.org/10.1016/..

15

Non-alcoholic fatty liver disease and subclinical atheroscl..:

Mondelli, A. ; Redheuil, A. ; Giral, P....
Atherosclerosis. 331 (2021) - p. e202-e203 , 2021

Link: https://doi.org/10.1016/..